In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on ProQR (PRQR – Research Report), with a price target of ...

I am glad that these negative results are finally shared, as it helps prevent duplication of work and unnecessary suffering in laboratory animals.” ...

ProQR (PRQR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jonathan Wolleben from JMP ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.08, a high estimate of $13.00, ...

Industry veterans John Maraganore, Ph.D., and Rachel Meyers, Ph.D., to provide strategic guidance on the company's RNA Actuating platform to develop a new class of RNA medicines that upregulate ...

Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through ...

Recent research published in the journal “Science Bulletin” detailed the creation of a tool called ChCas12b that can ...

GenScript Biotech, a global biotechnology leader in the life science, biologics manufacturing, synthetic biology, and cell ...

In molecular biology, RNA modifications were traditionally associated with static structural components like rRNAs and tRNAs. However, advancements such as antibody immunoprecipitation and ...

This study is led by Professor Yongming Wang's research team from Fudan University, in collaboration with the team led by Professor Renjie Chai from ...

In a paper published in Science Bulletin, a Chinese team of scientists conducted a GFP-activation assay screening 13 Cas12b ...